Qiaoli Wang MD, PhD Welcome to my personal webpage

Original articles

  1. Wang QL, Babic A, Rosenthal MH, Lee AA, Zhang Y, Zhang XH, Song MY, Rezende LFM, Lee DH, Biller L, Ng K, Giannakis M, Chan AT, Meyerhardt JA, Fuchs CS, et al. Cancer Diagnoses After Recent Weight Loss. JAMA. 2024;331(4):318-328. DOI: 10.1001/jama.2023.25869

  2. Wang QL, Ma C, Yuan C, Shi Q, Wolpin BM, Zhang Y, Fuchs CS, Meyer J, Zemla T, Cheng E, Kumthekar P, Guthrie KA, Couture F, Kuebler P, Kumar P, et al. Plasma 25-Hydroxyvitamin D Levels and Survival in Stage III Colon Cancer: Findings from CALGB/SWOG 80702 (Alliance). Clin Cancer Res. 2023;29(14):2621-30. DOI: 10.1158/1078-0432.CCR-23-0447

  3. Wang QL, Zhang Y, Zeng E, Grassmann F, He W, Czene K. Risk of estrogen receptor–specificbreast cancer by family history of estrogen receptor subtypes and other cancers. J Natl Cancer Inst. 2023; 115(9):1020-1028. DOI: 10.1093/jnci/djad104

  4. Wang QL, Santoni G, Lagergren J. Diabetes, metformin use, and survival in esophageal cancer: a population-based cohort study. JNCI Cancer Spectr. 2023;7(4). DOI: 10.1093/jncics/pkad043

  5. Zhang Y, Wang QL, Yuan C, Lee AA, Babic A, Ng K, Perez K, Nowak JA, Lagergren J, Stampfer MJ, Giovannucci EL, Sander C, Rosenthal MH, Kraft P, Wolpin BM. Pancreatic cancer is associated with medication changes prior to clinical diagnosis. Nat Commun. 2023;14(1):2437. DOI: 10.1038/s41467-023-38088-2

  6. Zhang Y, Wang QL, Zeng E, He W, Czene K. Analysis of Breast Cancer Family History, Estrogen Receptor Status, and Breast Cancer Outcomes in Sweden. JAMA Netw Open. 2023;6(6):e2318053. DOI: 10.1001/jamanetworkopen.2023.18053

  7. Yuan C, Wang QL, Kim H, Babic A, Zhang J, Wolpin BM, Wu K, Song M, Ogino S, Meyerhardt JA, Chan AT, Cao Y, Giovannucci EL, Ng K. Being breastfed in infancy and risk of colorectal cancer and precursor lesions. Clin Gastroenterol Hepatol. 2023; Sep 6:S1542-3565(23)00673-0. DOI: 10.1016/j.cgh.2023.08.023

  8. Meng XY, Wang QL, Shi MJ, Zhang HY. Historical pathogen-driven selection may contribute to contemporary ethnic difference in bladder cancer susceptibility. Bladder Cancer. 2023;9(3):211-216. DOI: 10.3233/BLC-230010

  9. Lee AA, Wang QL, Kim J, Babic A, Zhang X, Perez K, Ng K, Nowak J, Rifai N, Sesso HD, Buring JE, Anderson GL, Wactawski-Wende J, Wallace R, Manson JE, et al. Helicobacter pylori seropositivity, ABO blood type, and pancreatic cancer risk from 5 prospective cohorts. Clin Transl Gastroenterol. 2023;14(5):e00573. DOI: 10.14309/ctg.0000000000000573

  10. Babic A, Wang QL, Lee AA, Yuan C, Rifai N, Luo J, Tabung FK, Shadyab A, Wactawski-Wende J, Saquib N, Kim J, Kraft P, Sesso HD, Buring JE, Giovannucci EL, et al. Sex-specific associations between adiponectin and leptin signaling and pancreatic cancer survival. Cancer Epidemiol Biomarkers Prev. 2023; 32(10):1458–1469. DOI: 10.1158/1055-9965.EPI-23-0505

  11. Babic A, Rosenthal MH, Sundaresan TK, Khalaf N, Lee V, Brais LK, Loftus M, Caplan L, Denning S, Gurung A, Harrod J, Schawkat K, Yuan C, Wang QL, Lee AA, et al. Adipose tissue and skeletal muscle wasting precede clinical diagnosis of pancreatic cancer. Nat Commun. 2023;14(1):4317. DOI: 10.1038/s41467-023-40024-3

  12. Yuan C, Kim J, Wang QL, Lee AA, Babic A, PanScan/Pan CIIIIC, Amundadottir LT, Klein AP, Li D, McCullough ML, Petersen GM, Risch HA, Stolzenberg-Solomon RZ, Perez K, Ng K, et al. The age-dependent association of risk factors with pancreatic cancer. Ann Oncol. 2022;33(7):693-701. DOI: 10.1016/j.annonc.2022.03.276

  13. Yuan C, Joh HK, Wang QL, Zhang Y, Smith-Warner SA, Wang M, Song M, Cao Y, Zhang X, Zoltick ES, Hur J, Chan AT, Meyerhardt JA, Ogino S, Ng K, et al. Sugar-sweetened beverage and sugar consumption and colorectal cancer incidence and mortality according to anatomic subsite. Am J Clin Nutr. 2022;115(6):1481-9. DOI: 10.1093/ajcn/nqac040

  14. Wang QL, Song M, Clinton SK, Mucci LA, Lagergren J, Giovannucci EL. Longitudinal trajectories of lifetime body shape and prostate cancer angiogenesis. Eur J Epidemiol. 2022;37(3):261-270. DOI: 10.1007/s10654-021-00838-1

  15. Wang QL, Khil J, Hong S, Lee DH, Ha KH, Keum N, Kim HC, Giovannucci EL. Temporal association of total serum cholesterol and pancreatic cancer incidence. Nutrients. 2022;14(22):4938. DOI: 10.3390/nu14224938

  16. Nilsson M, Olafsdottir H, Alexandersson von Dobeln G, Villegas F, Gagliardi G, Hellstrom M, Wang QL, Johansson H, Gebski V, Hedberg J, Klevebro F, Markar S, Smyth E, Lagergren P, Al-Haidari G, et al. Neoadjuvant chemoradiotherapy and surgery for esophageal squamous cell carcinoma versus definitive chemoradiotherapy with salvage surgery as needed: the study protocol for the randomized controlled NEEDS trial. Front Oncol. 2022;12:917961. DOI: 10.3389/fonc.2022.917961

  17. Wang QL, Ness-Jensen E, Santoni G, Xie SH, Lagergren J. Development and validation of a risk prediction model for esophageal squamous cell carcinoma using cohort studies. Am J Gastroenterol. 2021;116(4):683-691. PMID: 33617173, DOI: 10.14309/ajg.0000000000001094

  18. Wang QL, Lagergren J. Response to Lai. Am J Gastroenterol. 2021;116(8):1758. DOI: 10.14309/ajg.0000000000001312

  19. Mei J, Hu W, Chen Q, Li C, Chen Z, Fan Y, Tian S, Zhang Z, Li B, Ye Q, Yue J, Wang QL . Development and external validation of a COVID-19 mortality risk prediction algorithm: a multicentre retrospective cohort study. BMJ Open. 2020 12 24; 10(12):e044028. PMID: 33361083, DOI: 10.1136/bmjopen-2020-044028

  20. Wang QL, Santoni G, Ness-Jensen E, Lagergren J, Xie SH. Association Between Metformin Use and Risk of Esophageal Squamous Cell Carcinoma in a Population-Based Cohort Study. Am J Gastroenterol. 2020 01; 115(1):73-78.. PMID: 31821177, DOI: 10.14309/ajg.0000000000000478

  21. Wang QL, Lagergren J, Xie SH. Prediction of individuals at high absolute risk of esophageal squamous cell carcinoma. Gastrointest Endosc. 2019 04; 89(4):726-732.e2. PMID: 30616974, DOI: 10.1016/j.gie.2018.10.025

  22. Wang QL, Xie SH, Wahlin K, Lagergren J. Global time trends in the incidence of esophageal squamous cell carcinoma. Clin Epidemiol. 2018; 10:717-728'. PMID: 29950901, DOI: 10.2147/CLEP.S166078

  23. Wang QL, Xie SH, Li WT, Lagergren J. Smoking Cessation and Risk of Esophageal Cancer by Histological Type: Systematic Review and Meta-analysis. J Natl Cancer Inst. 2017 12 01; 109(12). PMID: 29933436, DOI: 10.1093/jnci/djx115

  24. Yang H, Zhang H, Zhong Y, Wang Q, Yang L, Kang H, Gao X, Yu H, Xie C, Zhou F, Zhou Y. Concomitant underexpression of TGFBR2 and overexpression of hTERT are associated with poor prognosis in cervical cancer. Sci Rep. 2017 02 14; 7:41670. PMID: 28195144, DOI: 10.1038/srep41670

  25. Qi Y, Wei Y, Wang Q, Xu H, Wang Y, Yao A, Yang H, Gao Y, Zhou F. Heteroplasmy of mutant mitochondrial DNA A10398G and analysis of its prognostic value in non-small cell lung cancer. Oncol Lett. 2016 Nov; 12(5):3081-3088. PMID: 27899967, DOI: 10.3892/ol.2016.5086

  26. Guan GG, Wang WB, Lei BX Wang QL, Wu L, Fu ZM, Zhou FX, Zhou YF. UBE2D3 is a positive prognostic factor and is negatively correlated with hTERT expression in esophageal cancer. Oncol Lett. 2015 Apr; 9(4):1567-1574'. PMID: 25789002, DOI: 10.3892/ol.2015.2926

  27. Wang Q, Qi Y, Zhang D, Gong C, Yao A, Xiao Y, Yang J, Zhou F, Zhou Y. Electrolyte disorders assessment in solid tumor patients treated with anti-EGFR monoclonal antibodies: a pooled analysis of 25 randomized clinical trials. Tumour Biol. 2015 May; 36(5):3471-82. PMID: 25542231, DOI: 10.1007/s13277-014-2983-9

  28. Wang Q, Han X, Li J, Gao X, Wang Y, Liu M, Dong G, Yue J. Regulation of cerebral CYP2D alters tramadol metabolism in the brain: interactions of tramadol with propranolol and nicotine. Xenobiotica. 2015 Apr; 45(4):335-44. PMID: 25387586, DOI: 10.3109/00498254.2014.981609

  29. Yao A, Wang Y, Peng X, Ye R, Wang Q, Qi Y, Zhou F. Predictive value of excision repair cross-complementation group 1 expression for platinum-based chemotherapy and survival in gastric cancer: a meta-analysis. J Cancer Res Clin Oncol. 2014 Dec; 140(12):2107-17. PMID: 25387586, DOI: 10.1007/s00432-014-1758-4

Conference contributions

  1. Wang QL, Babic A, Rosenthal MH, Lee AA, Zhang Y, Zhang X, Song M, Rezende LF, Lee DH, Biller L, Ng K, Chan AT, Stampfer MJ, Giovannucci EL, Kraft P, et al. Weight loss and subsequent cancer diagnosis: A prospective cohort study. Cancer Res. 2022;82(12_Supplement):5934. DOI: 10.1158/1538-7445.AM2022-5934

  2. Yuan C, Kim J, Wang QL, Lee AA, Babic A, Amundadottir LT, Klein AP, Li D, McCullough ML, Petersen GM, Risch HA, Stolzenberg-Solomon RZ, Perez K, Ng K, Giovannucci EL, et al. Weight loss and subsequent cancer diagnosis: A prospective cohort study. Cancer Res. 2022;82(12). DOI: 10.1158/1538-7445.AM2022-5891

  3. Lee AA, Wang QL, Kim J, Babic A, Zhang X, Perez K, Ng K, Sesso H, Manson JE, Giovannucci E, Stampfer M, Kraft P, Yuan C, Wolpin B. Helicobacter pylori seropositivity and pancreatic cancer risk. Gastroenterology. 2022;162(7):S733-S. DOI: 10.1016/S0016-5085(22)61729-3

  4. Wang QL, . Diabetes and Metformin Use in Association With Survival in Esophageal Cancer. Am J Gastroenterol. 2021;116:S199. DOI: 10.14309/01.ajg.0000774264.05884.e6

  5. Wang QL, . Decreased risk of esophageal squamous cell carcinoma among metformin users in a population-based cohort study. J Clin Oncol. 2019;37(15). DOI: 10.1200/JCO.2019.37.15_suppl.e15507